HDL Cholesterol Kits – Feasibly Instrumenting the Early Diagnosis of CVDs
With technological advances penetrating deeper into healthcare systems, the field of diagnostics has been witnessing a radical shift from ‘lengthy’ process to ‘ready in seconds’ results. On a similar line, HDL (high density lipoproteins) cholesterol kits have gained considerable traction among laboratories and healthcare settings, offering specialized services in cardiovascular disease (CVD) risk assessment. In addition, a rising trend of point-of-care testing and self-testing by point of care cholesterol monitoring devices is highly likely to benefit sales of HDL cholesterol kits.
HDL Cholesterol Kits Market - Key Research Findings
Global HDL cholesterol kits market size was ~ US$ 480 Mn in 2018.
The HDL cholesterol kits market is expected to grow at a healthy CAGR of 5.0% over 2019-2029.
North America and Europe are expected to represent higher market value shares in the HDL cholesterol kits market
North America and Europe are among the higher revenue contributor regions in the HDL cholesterol kits market due to the high adoption of preventive healthcare among the population and the increasing prevalence of dyslipidaemia due to obesity and diabetes.
Acquisitions and partnerships between companies are expected to propel the growth prospects of the HDL cholesterol kits market
Major players in the HDL cholesterol kits market, such as Abbott Laboratories, Fujifilm Holding Corporation, Abcam PLC, and others, are focusing on acquisitions and partnerships. For instance, in October 2017, Abbott entered into a definitive agreement to acquire Alere Inc., a diagnostic device and service provider.
HDL and LDL/VLDL assay kits are expected to remain the most preferred product type segment of the HDL cholesterol kits market
The growth of this segment can be primarily attributed to the higher demand for combination testing products for both parameter HDL and LDL/VLDL cholesterol testing.
Top 2 Factors Shaping the HDL Cholesterol Kits Market
Growing Importance of Cholesterol Screening among Diabetic Patients to Boost Growth of the HDL Cholesterol Kits Market
According to the World Health Organization, the global prevalence of diabetes has increased gradually from 108 Mn people in 1980 to 422 Mn people in 2014. Diabetes prevalence has been growing more rapidly in low- and middle-income countries.
Cholesterol testing is also very important among diabetic patients as diabetes tends to lower the level of high-density lipoprotein (good cholesterol) and increase the level of triglyceride & low-density lipoprotein (bad cholesterol). These conditions among diabetic patients are known as diabetic dyslipidaemia.
Diabetic dyslipidaemia increases the risk of atherosclerosis and coronary artery diseases. Therefore, the diagnosis and screening of cholesterol is important among diabetic patients, which is expected to boost the demand for HDL cholesterol kits over the forecast period.
Rising Low HDL Cholesterol Prevalence Pool to Propel the Demand for HDL Cholesterol Kits
Cholesterol occurs due to multiple factors that involve certain aspects of a person’s lifestyle or certain medical conditions. These factors include low or high fat percentage in the body, high sugar intake, lack of exercise, liver disease, alcohol abuse, untreated hypothyroidism, cigarette smoking, and uncontrolled diabetes.
All these above-mentioned factors increase the need for cholesterol testing, thus boosting the growth of the global HDL cholesterol kits market.
HDL Cholesterol Kits Market Structure Analysis
The global HDL cholesterol kits market is a fragmented market owing to the presence of a number of major market players and regional players.
Some of the prominent companies in the HDL cholesterol kits market include Thermo Fisher Scientific, Abbott Laboratories, Diazyme Laboratories, Inc., Hoffmann-La Roche Ltd., Randox Laboratories Limited, Fujifilm Holding Corporation, Abcam plc., Merck KGaA, Danaher Corporation (Beckman Coulter Inc.), PerkinElmer, Inc., and others.
Most of the players in the HDL cholesterol kits market maintain a strategic focus on the development of new products and acquisitions & partnerships with regional and global players.
Some of the top manufacturers that contribute a high revenue share in the HDL cholesterol kits market are the
- Abbott Laboratories,
- Danaher Corporation,
- Hoffmann-La Roche Ltd.,
- Fujifilm Holding Corporation.
Market Set to Grow 1.6X between 2019 and 2029
Global demand for HDL cholesterol kits is majorly accounted by high prevalence of CVDs and lifestyle diseases. Attributing to the increasing number of awareness programs encouraging people to actively go for cholesterol testing before following any cholesterol medicine regime, HDL cholesterol kits market is expected to grow at a significant rate.
'Boosting Awareness' Is the Key to Invade Developing Regions
Advanced healthcare systems, along with greater awareness and availability of new medical devices, continue to solidify top ranking positions of North America and Europe, in the HDL cholesterol kits industry. In East Asian markets, increasing healthcare screening initiatives by governments and non-government/private entities are improving the value of care, which is likely to uplift the prospects of HDL cholesterol kits market within the region.
The Broader Perspective
Stakeholders in HDL cholesterol kits market are focused on their alignment with evolving healthcare trends, which also include specific patient requirements. In addition to strengthening the position through acquisition of other players, manufacturers are targeting new launches in the point-of-care HDL cholesterol kits category, for rapid and real-time results.
HDL and LDL/VLDL assay kit remains top selling category
Demand for HDL cholesterol direct reagent kit to grow significantly
Hospitals remain top end users with over 50% revenue share
Demand from diagnostic laboratories to witness robust growth
How Growth will Unfold
HDL and LDL/VLDL assay kits continue to remain the most lucrative categories in market, whereas HDL cholesterol direct reagent kits are becoming an important part of the manufacturers’ strategies designed for extension of products portfolio.
HDL and LDL/VLDL Assay Kit | HDL Cholesterol Direct Reagent Kit | HDL Cholesterol Precipitating Reagent Kit
* This data is only a representation. Actual data may vary and will be available in report.Click Here To Know How The Growth Will Unfold
Custom Market Research Services
FMI offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.
HDL Cholesterol Kits Market: Global Industry Analysis 2014-2018 & Opportunity Assessment 2019-2029
A recent market study published by FMI “HDL Cholesterol Kits Market: Global Industry Analysis 2014-2018 & Forecast 2019-2029” offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historic as well as current growth parameters of the HDL cholesterol kits market, the growth prospects of the market are obtained with maximum precision.
HDL Cholesterol Kits Market Taxonomy
The global HDL cholesterol kits market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach in front of the reader.
By Product Type
- HDL Cholesterol Precipitating Reagent Kit
- HDL Cholesterol Direct Reagent Kit
- HDL and LDL/VLDL Assay Kit
By End User
- Diagnostic Laboratories
- North America
- Latin America
- South Asia
- East Asia
- Middle East & Africa
The report commences with the executive summary of the HDL cholesterol kits market, which includes a summary of the key findings and key statistics of the market. It also includes the market value (US$ million) estimates of the leading segments of the HDL cholesterol kits market.
Readers can find the detailed taxonomy and the definition of the HDL Cholesterol Kits market in this chapter, which will help them understand the basic information about the HDL cholesterol kits market. This section also highlights the inclusions and exclusions, which helps the reader understand the scope of the HDL cholesterol kits market report.
The report provides key market trends that are expected to impact the market growth significantly during the forecast period. Detailed industry trends are provided in this section, along with key market development or product innovations.
This section explain the global market value analysis and forecast for the HDL cholesterol kits market between the forecast periods of 2014-2029 is highlights in this section. This chapter includes the detailed analysis of the historical HDL cholesterol kits market, along with an opportunity analysis of the future. Readers can also find the absolute opportunity for the current year (2019 – 2020), and an incremental opportunity for the forecast period (2019 – 2029).
This chapter explains the key macro-economic factors that are expected to influence the growth of the HDL cholesterol kits market over the forecast period. Along with macroeconomic factors, this section also highlights the opportunity analysis for the HDL cholesterol kits market. This chapter also highlights the key market dynamics of the HDL cholesterol kits market, which include the drivers, restraints and trends. Moreover, readers will understand the key trends followed by the leading manufacturers in the HDL Cholesterol Kits market.
Based on product type, the HDL cholesterol kits market is segmented into HDL cholesterol precipitating reagent kit, HDL cholesterol direct reagent kit, and HDL and LDL/VLDL assay kit . In this chapter, readers can find information about the key trends and developments in the HDL cholesterol kits market and market attractiveness analysis based on the product type.
This chapter provides details about the HDL Cholesterol Kits market on the basis of end user, and has been classified into hospitals, Clinics, and Diagnostic Laboratories. In this chapter, readers can understand the market attractive analysis based on end user.
This chapter explains how the HDL cholesterol kits market will grow across various geographic regions, such as North America, Latin America, Europe, East Asia, South Asia, Oceania, the Middle East & Africa (MEA)
This chapter includes a detailed analysis of the growth of the North America HDL cholesterol kits market, along with a country-wise assessment that includes the U.S. and Canada. Readers can also find the regional trends, regulations, and market growth based on the end users and countries in North America.
Readers can find detailed information about several factors, such as the pricing analysis and the regional trends, which are impacting the growth of the Latin America HDL cholesterol kits market. This chapter also includes the growth prospects of the HDL cholesterol kits market in the leading LATAM countries such as Brazil, Mexico, Argentina, and the Rest of Latin America.
Important growth prospects of the HDL cholesterol kits market based on its end users in several countries, such as Germany, the UK, France, Spain, Italy, Russia, and the Rest of Europe, are included in this chapter.
India, Indonesia, Thailand , Malaysia are the leading countries in the South Asia region that are the prime subjects of assessment to obtain the growth prospects of the South Asia HDL cholesterol kits market in this chapter. Readers can find detailed information about the growth parameters of the South Asia HDL cholesterol kits market during the period 2019-2029.
This chapter highlights the growth of the HDL cholesterol kits market in the East Asia by focusing on China, Japan and South Korea. This section also helps readers understand the key factors that are responsible for the growth of the HDL cholesterol kits market in East Asia.
In this chapter, Australia and New Zealand are among the leading countries in the Oceania region, which are the prime subjects of assessment to obtain the growth prospects of the Oceania HDL cholesterol kits market.
This chapter provides information about how the HDL cholesterol kits market will grow in the major countries in the MEA region, such as GCC Countries, South Africa, Turkey, Northern Africa and the rest of MEA, during the forecast period 2019 - 2029.
In this chapter, readers can find a detailed information about the tier analysis and market concentration of the key players in the HDL cholesterol kits market along with their market presence analysis by region and product portfolio.
In this chapter, readers can find a comprehensive list of all the leading stakeholders in the HDL cholesterol kits market, along with detailed information about each company, which includes the company overview, revenue shares, strategic overview, and recent company developments. Some of the market players featured in the report are Thermo Fisher Scientific, Abbott Laboratories, Diazyme Laboratories, Inc., Hoffmann-La Roche Ltd., Randox Laboratories Limited, Fujifilm Holding Corporation, Abcam plc., Merck KGaA, Danaher Corporation (Beckman Coulter Inc.), PerkinElmer, Inc., and others.
This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the HDL cholesterol kits report.
This chapter helps readers understand the research methodology followed to obtain the various conclusions as well as important qualitative and quantitative information about the HDL cholesterol kits market.
How the research was conducted?
- C - Level Executives
- Marketing Directors
- Sales Heads
- Portfolio Managers
- Purchasing Managers
- Medical Officers
- Device and Kits Development Heads
- Strategy Advisors
- R&D Managers
- Product Manufacturers
- Component Suppliers / OEMs
- Hospital Purchasing Departments
- Physicians / Lab Technicians
- Industry Experts
- Current Market Dynamics and Challenges
- Market Characteristics
- Market Performance and Growth Quadrants
- Competition Structure and Market Structure
- Strategic Growth Initiatives
- Product Adoption, Usage Pattern
- Regulatory Landscape
- Products in Pipeline and Clinical Development
- Near-term and Long-term Market Growth Prospects
- Market Segment Splits and Authenticity
- Opinions on Market Projections and Validity of Assumptions
- Industry Magazines
- American Heart Association
- American College of Cardiology
- American Academy of Family Physicians
- National Institutes of Health
- Center of Disease Control & Prevention
- Company Press Releases
- Annual Reports and Investor Presentations
- Peer-reviewed Journals
- Government Websites and Publications
- Trade Websites
- Clinical Trial Registries
- Country-specific Regulatory Authorities
- World Bank, WHO, IMF, OECD
Primary Interview Splits